IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Ventures Fund IV General Partner LLC

Q4 2015 Holdings

Filed 2016-02-12 | 3 holdings | $506.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$494.2K14,083,57997.5%
T2 Biosystems, Inc.COM89853L104$8.1K741,7551.6%
Eleven Biotherapeutics, Inc.COM286221106$4.4K1,466,4170.9%